Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 26, 2019
GENEWIZ announced the opening of its European headquarters for its genomics business in Leipzig, Germany.
read more
CUNY (City University of New York) and Genestack Ltd are pleased to announce their collaboration aimed at streamlining data curation for the BioConductor program.
read more
GBG and its CRO arm GD3 has acquired the Berkeley-based CRO Integrated Analytical Solutions.
read more
Genesis Drug Discovery & Development has announced the appointment of Olesia Buiakova, M.D., Ph.D., the Chief Scientific Officer of Invivotek as its new Chief Scientific Officer.
read more
Thursday, September 30, 2021
Genesis Drug Discovery & Development (GD3), the contract research organization (CRO) arm of Genesis Biotechnology Group® (GBG), has announced the appointment of Anthony Rohr, current Chief Executive Officer of PharmOptima, as its new Chief Operating ...
read more
Wednesday, November 07, 2018
Genesis Biotechnology Group and GD3 has entered into a partnership with Yale University.
read more
Wednesday, December 09, 2020
GBG and its CRO arm GD3 has expanded its relationship with Yale University to continue to offer GD3's integrated portfolio of preclinical services to the awardees of the Blavatnik Fund for Innovation.
read more
Tuesday, November 19, 2019
Genesis Drug Discovery & Development has acquired New England Discovery Partners, a CRO specializing in synthetic and medicinal chemistry.
read more
Monday, December 07, 2020
Generis has announced its strategic partnership with Cognizant to deliver information management solutions for Life Sciences.
read more
Wednesday, September 22, 2021
GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has contracted Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO), to ...
read more
Friday, November 06, 2015
The Pulmonary Fibrosis Foundation (PFF), the leading pulmonary fibrosis resource, has announced that Genentech, a leading biotechnology company and a member of the Roche Group, will be the Founding Partner for the PFF Patient Registry program ...
read more
Ajinomoto Bio-Pharma Services announced GeneDesign has joined the global organization.
read more
Monday, September 24, 2018
GeneCentric Therapeutics announced that the company has acquired an exclusive license from the UNC at Chapel Hill to technology for subtyping Pancreatic Ductal Adenocarcinoma.
read more
GeneCentric Therapeutics has acquired Select ImmunoGenomics, a Chapel Hill, NC-based provider of advanced immunogenomic, data analysis and biomarker development services to support the development of immuno-oncology drugs. The acquisition provides ...
read more
Ascend Gene & Cell Therapies (Ascend), a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for gene therapy technologies, announces today that it has launched as a facilitator for...
read more